Astrocyte Pharma is developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders.
Spark (Sport and Real Knowledge P/L) is dedicated to harnessing the power of world class science and research to protect and enhance the sports we love, and those that play them.
StarFast
The STARFAST Phase 2 clinical trial is now underway in Adelaide, Australia, testing whether the investigational drug AST-004 can reduce brain injury effects and support faster recovery in athletes.
Sportsmed is a leading South Australian sports medicine provider, supporting the Spark clinical concussion trial in Adelaide with clinical expertise and care.
The Royal Adelaide Hospital is South Australia’s flagship hospital, providing complex clinical care to an estimated 85,000 inpatients and 400,000 outpatients annually.